In 2015, the United Nations adopted the 17 Sustainable Development Goals (SDGs) as a global blueprint for addressing pressing challenges. These goals guide our efforts to combat poverty, inequality, climate change, and environmental concerns. Among them, two pivotal goals stand out – SDG 3: Good Health and Well-being, and SDG 9: Industry, Innovation and Infrastructure. With the relentless impact of the COVID-19 pandemic, the importance of achieving these goals has never been clearer. In this context, the EU-funded COVend project stands out as a perfect example of contribution to these goals and shaping a healthier world.

SDG 3 focuses on ensuring healthy lives and well-being for all. It aims to reduce maternal and child mortality, fight diseases, and achieve universal health coverage. In alignment with this goal, COVend is working towards developing a therapy for SARS-CoV-2 during mild and moderate stages of COVID-19. This includes preventing the progression to severe illness through the testing of the peptide FX06 in multi-national Phase II/III trials. The project, backed by the EU, is making great strides in its mission to improve global health.

Moreover, through the IXION clinical trial and scientific advancements, COVend is also making significant contributions to SDG 9. This goal emphasises the importance of resilient infrastructure, sustainable industrialisation, and fostering innovation for economic growth and inclusivity. By embracing innovation and supporting the development of advanced medical solutions, COVend is not only contributing to healthcare infrastructure but also driving economic progress and inclusivity.

As the world continues to face the challenges brought by the COVID-19 pandemic, it is more important than ever to work together towards achieving these goals. The COVend project, aligned with the UN SDGs, is a perfect example of how collaboration and innovation can drive sustainable progress for all.